CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC.
6Patents
6Active
6Granted
47Portfolio score
Filing activity: Oct 14, 2005 → Sep 17, 2018 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7718169B2 | Compositions and methods for treating pancreatic insufficiency | Human Necessities | 55 | Active |
| US8513242B2 | Pyrimidine compounds and methods of making and using same | Chemistry; Metallurgy | 30 | Active |
| US10208053B2 | Bicyclic heteroaryl derivatives as CFTR potentiators | Human Necessities | 30 | Active |
| US10131670B2 | Bicyclic heteroaryl derivatives as CFTR potentiators | Human Necessities | 26 | Active |
| US8334292B1 | Pyrimidine compounds and methods of making and using same | Chemistry; Metallurgy | 5 | Active |
| US10301315B2 | Pyrrolopyrimidines as CFTR potentiators | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.